Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects. [electronic resource]
Producer: 20160614Description: 610-8 p. digitalISSN:- 1520-7560
- Acetaminophen -- blood
- Adult
- Analgesics, Non-Narcotic -- blood
- Blood Glucose -- analysis
- C-Peptide -- blood
- Cross-Over Studies
- Dose-Response Relationship, Drug
- Female
- Gastric Emptying -- drug effects
- Gastrointestinal Agents -- blood
- Glucagon -- blood
- Glucagon-Like Peptide-1 Receptor -- metabolism
- Humans
- Hypoglycemic Agents -- administration & dosage
- Injections, Subcutaneous
- Insulin -- agonists
- Insulin Secretion
- Intestinal Absorption -- drug effects
- Male
- Peptides -- administration & dosage
- Postprandial Period
- Young Adult
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.